Cargando…
Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy
Studies of mouse models of Alzheimer's disease (AD) have demonstrated that nitric oxide synthase 2 (NOS2) is involved in AD pathology. However, the effects of NOS2 on the pathology of Parkinson’s disease (PD) are not well studied. To address this gap, we examined the impact of NOS2 on disease-a...
Autores principales: | Kim, Jieun, Han, Jung-Youn, Lee, Yujeong, Kim, Kipom, Choi, Young Pyo, Chae, Sehyun, Hoe, Hyang-Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841612/ https://www.ncbi.nlm.nih.gov/pubmed/36647152 http://dx.doi.org/10.1186/s13041-023-00996-1 |
Ejemplares similares
-
Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
por: Choi, Hee-Jeong, et al.
Publicado: (2022) -
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020) -
Profiling tyrosine kinase inhibitors as AD therapeutics in a mouse model of AD
por: Lee, Hyun-ju, et al.
Publicado: (2023) -
Cell-type-specific DNA methylation analysis of the frontal cortices of mutant Polg1 transgenic mice with neuronal accumulation of deleted mitochondrial DNA
por: Sugawara, Hiroko, et al.
Publicado: (2022) -
The phosphorylation status of eukaryotic elongation factor-2 indicates neural activity in the brain
por: Yoon, Sang Ho, et al.
Publicado: (2021)